{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:19:36Z","timestamp":1759529976978},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jpsychires.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,10,11]],"date-time":"2010-10-11T14:47:22Z","timestamp":1286808442000},"page":"756-762","source":"Crossref","is-referenced-by-count":12,"title":["Aripiprazole versus haloperidol treatment in early-stage schizophrenia"],"prefix":"10.1016","volume":"45","author":[{"given":"Ragy R.","family":"Girgis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislav R.","family":"Vorel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Edward Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Kimberly Portland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrei","family":"Pikalov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2010.09.003_bib45","doi-asserted-by":"crossref","unstructured":"American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care 2004; 27: 596\u2013601.","DOI":"10.2337\/diacare.27.2.596"},{"year":"1994","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.jpsychires.2010.09.003_bib1"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib2","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4088\/JCP.v68n0104","article-title":"Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: a randomized trial","volume":"68","author":"Chan","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib4","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1176\/ajp.152.12.1724","article-title":"Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients","volume":"152","author":"Chatterjee","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-006-0564-3","article-title":"Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine","volume":"189","author":"Chrzanowski","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.4088\/JCP.v67n1004","article-title":"A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis","volume":"67","author":"Crespo-Facorro","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1017\/S1092852900014784","article-title":"The efficacy and safety of lower doses of aripiprazole for the treatment of patients with acute exacerbation of schizophrenia","volume":"11","author":"Cutler","year":"2006","journal-title":"CNS Spectrums"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/oxfordjournals.schbul.a033413","article-title":"Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone working group","volume":"25","author":"Emsley","year":"1999","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopsych.2008.07.033","article-title":"A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia","volume":"65","author":"Fleischhacker","year":"2009","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib11","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.4088\/JCP.v68n1116","article-title":"Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German research network on schizophrenia","volume":"68","author":"Gaebel","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib12","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/bmj.321.7273.1371","article-title":"Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis","volume":"321","author":"Geddes","year":"2000","journal-title":"British Medical Journal"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2006.06.021","article-title":"Olanzapine and haloperidol in first episode psychosis: two-year data","volume":"86","author":"Green","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib14","series-title":"ECDEU assessment Manual for Psychopharmacology","first-page":"534","article-title":"Abnormal Involuntary Movement scale (AIMS)","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib15","series-title":"ECDEU assessment Manual for Psychopharmacology","first-page":"217","article-title":"Clinical Global Impressions","author":"Guy","year":"1976"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib16","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(08)60486-9","article-title":"Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial","volume":"371","author":"Kahn","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib17","doi-asserted-by":"crossref","first-page":"763","DOI":"10.4088\/JCP.v63n0903","article-title":"Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder","volume":"63","author":"Kane","year":"2002","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.schres.2007.05.009","article-title":"Symptomatic remission in schizophrenia patients treated with aripiprazole or haloperidol for up to 52 weeks","volume":"95","author":"Kane","year":"2007","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF03256145","article-title":"Comparative utility of aripiprazole and haloperidol in schizophrenia: post hoc analysis of two 52-week, randomized, controlled trials","volume":"7","author":"Kane","year":"2009","journal-title":"Applied Health Economics and Health Policy"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v68n0206","article-title":"Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine","volume":"68","author":"Kane","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia","volume":"6","author":"Kasper","year":"2003","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib23","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib24","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/S0140-6736(03)13306-5","article-title":"New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis","volume":"361","author":"Leucht","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib25","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.npp.1300157","article-title":"Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine","volume":"28","author":"Lieberman","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib26","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1176\/appi.ajp.160.8.1396","article-title":"Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol","volume":"160","author":"Lieberman","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib27","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archpsyc.62.4.361","article-title":"Antipsychotic drug effects on brain morphology in first-episode psychosis","volume":"62","author":"Lieberman","year":"2005","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpsychires.2007.05.002","article-title":"A randomized, double-blind, placebo-controlled, study of the efficacy and safety of aripiprazole 10, 15 or 20\u00a0mg\/day for the treatment of patients with acute exacerbations of schizophrenia","volume":"41","author":"McEvoy","year":"2007","journal-title":"Journal of Psychiatric Research"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib29","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1991.01810320063009","article-title":"Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose","volume":"48","author":"McEvoy","year":"1991","journal-title":"Archives of General Psychiatry"},{"issue":"65 Suppl","key":"10.1016\/j.jpsychires.2010.09.003_bib30","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"18","author":"McQuade","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib31","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4088\/JCP.v68n1210","article-title":"Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis","volume":"68","author":"Miller del","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib33","series-title":"Psychiatry","first-page":"2161","article-title":"Antipsychotic drugs","author":"Miyamoto","year":"2008"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib34","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib35","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4088\/JCP.v69n0702","article-title":"A multicenter, randomized, double-blind study of the effects of\u00a0aripiprazole in overweight subjects with schizophrenia or schizoaffective disorder switched from olanzapine","volume":"69","author":"Newcomer","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib36","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/070674370605100803","article-title":"The metabolic effects of antipsychotic medications","volume":"51","author":"Newcomer","year":"2006","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib37","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.4088\/JCP.v64n0910","article-title":"Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study","volume":"64","author":"Pigott","year":"2003","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib38","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Archives of General Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/appi.ps.56.1.85","article-title":"Open forum: effectiveness versus efficacy of second-generation antipsychotics: haloperidol without anticholinergics as a comparator","volume":"56","author":"Rosenheck","year":"2005","journal-title":"Psychiatric Services"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib40","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/01.jcp.0000130557.08996.7a","article-title":"A double-blind, randomized study of olanzapine and olanzapine\/fluoxetine combination for major depression with psychotic features","volume":"24","author":"Rothschild","year":"2004","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1176\/ajp.156.1.79","article-title":"Olanzapine versus haloperidol treatment in first-episode psychosis","volume":"156","author":"Sanger","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1176\/appi.ajp.162.5.947","article-title":"Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial","volume":"162","author":"Schooler","year":"2005","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplement"},{"key":"10.1016\/j.jpsychires.2010.09.003_bib44","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1192\/bjp.187.6.537","article-title":"Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol","volume":"187","author":"Zipursky","year":"2005","journal-title":"British Journal of Psychiatry"}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395610002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T11:11:56Z","timestamp":1559733116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395610002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0022395610002700"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2010.09.003","relation":{},"ISSN":["0022-3956"],"issn-type":[{"type":"print","value":"0022-3956"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}